GENFIT/GNFT

$3.68

0.82%
-
1D1W1MYTD1YMAX

About GENFIT

Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The Company is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver, such as Nonalcoholic steatohepatitis (NASH) or the bowel, such as the inflammatory bowel disease. The Company targets a number of therapeutic areas, which includes nonalcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC), NASH diagnosis, NASH-induced fibrosis and IL-17 dependent autoimmune diseases. The Company’s research programs develop diversified pipeline of drug candidates, including Elafibranor in NASH, which is in phase III; Elafibranor in PBC, which is in phase II; In-Vitro diagnostic test for NASH and Nitazoxanide in fibrosis, which is still in clinical stage, among others.

Ticker

GNFT

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Jean-Francois Mouney

Employees

154

Headquarters

Loos, France

GENFIT Metrics

BasicAdvanced
$178.99M
Market cap
-
P/E ratio
-$0.74
EPS
1.09
Beta
-
Dividend rate

GENFIT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-135.94% profit margin
QuarterlyAnnual
Q2 23
QoQ growth
Revenue
€15.3M
6.99%
Net income
€-20.8M
56.39%
Profit margin
-135.94%
46.17%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
ADR

Upcoming events

Buy or sell GENFIT stock

Buy or sell GENFIT stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing